Novartis plans to acquire Avidity Biosciences to add RNA therapeutics to its neuroscience biz to target rare genetic ...
An update from PYC Therapeutics Limited ( ($AU:PYC) ) is now available. PYC Therapeutics Limited announced significant progress in its drug ...
According to the agreement, Avidity ( NASDAQ: RNA) shareholders will receive $72 a share in cash, a 46% premium to Friday’s ...
In the enterprise sales segment, data chaos is felt especially acutely. The larger the company, the more complex lead management becomes: sources are scattered, information becomes outdated, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback